Posts

Showing posts with the label USFDA

Importance of guidelines in medical writing

Image
  In the realm of medical writing, guidelines serve as the North Star, guiding authors through the intricate constellation of precision and clarity, importance of guidelines in medical writing Introduction:  Documents that offer direction or recommendations on how to create particular sorts of medical documents are known as guidelines in t he field of medical writing. Typically, they are created by professional associations like the American Medical Writers Association (AMWA) or the  International  Council  for  Harmonisation  of Technical Requirements for Pharmaceuticals for Human Use (ICH) . The objective behind providing guidelines is the standardization of data.  Guidelines in Regulatory Medical Writing Documents Purpose:    Guidelines may address a variety of subjects, such as: Medical document format and organization Language and terminology employed Reporting the results of clinical trials Creating informed consent documents...

CFR Charting the Course for USFDA-Regulated Clinical Trials

Image
Unlocking the Regulatory Treasure Chest: CFR Charting the Course for USFDA-Regulated Clinical Trials Introduction: It's crucial to understand the numerous parts of clinical research that are governed by the Code of Federal Regulations (CFR) when conducting clinical trials in the United States. The U.S. Food and Drug Administration (FDA) and other government agencies enforce the regulations found in the CFR. Following are some significant CFR titles and sections pertaining to clinical trials: The code of Federation regulation is a compilation of proposed rules and regulations. This CFR is divided into 50 parts that represent areas subject to Federal regulations. Section 21 of CSR consists of most of the regulations of food and drugs.  Important CFRs available for clinical trials by the USFDA: CFR Title CFR Part Description Title 21 Part 11 Electronic Records; Electronic Signatures Title 21 Part 16 Regulatory Hearing Before the Food and Drug Administration Title 21 Part 50 Protection...